Navigation Links
Micromet Added to Russell 3000 Index
Date:6/29/2009

BETHESDA, Md., June 29 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it was added to the Russell 3000 Index as part of the annual reconstitution of the Russell indexes, which occurred on June 26, 2009.

"Investors recognize the Russell 3000 as an established benchmark for tracking investment performance, market movements and market trends. We are pleased that Micromet has been added to the Russell 3000 Index and expect that it will increase our visibility in the investment community," said Buck Phillips, Senior Vice President and Chief Financial Officer of Micromet.

Annual reconstitution of Russell's U.S. indexes captures the largest U.S. stocks as of the end of May, determined by total market capitalization. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes. The Russell 3000 also serves as the U.S. component to the Russell Global Index, which Russell launched in 2007.

Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. An industry-leading $4 trillion in assets currently are benchmarked to the Russell indexes. These investment tools originated from Russell's multi-manager investment business in the early 1980s when the company saw the need for a more objective, market-driven set of benchmarks in order to evaluate outside investment managers.

Total returns data for the Russell 3000 and other Russell indexes is available at www.russell.com/Indexes/performance/def
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Micromet to Host Conference Call and Webcast to Discuss Blinatumomab Data Presented at EHA on June 8, 2009
2. Micromet Presents Update at ASCO 2009 on a Phase 1b Combination Study of Adecatumumab and Docetaxel
3. Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO
4. Micromet, Inc. to Host Conference Call and Webcast to Report First Quarter 2009 Financial Results on May 6, 2009
5. Micromet Presents Data at AACR Meeting Showing Elimination of Colorectal Cancer Stem Cells by BiTE Antibody MT110
6. Micromet to Present at the Future Leaders in the Biotech Industry Conference on April 2, 2009
7. Micromet Adds Sir Walter Bodmer and Bernard Fox to Its Advisory Panel for BiTE Antibody Therapeutics
8. Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research
9. Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008
10. Micromet to Present at the Cowen Health Care Conference on March 17, 2009
11. Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 Quorum Review IRB, the industry ... large clinical trials called Quick Step™ . The offering ... address the research industry’s need for seamless study start-up with ... available for studies planning 50 or more North American investigator ... North American site count of 80 or more. Qualifying studies ...
(Date:7/22/2014)... Jersey , 22. Juli 2014 ... Life-Sciences-Industrie, hat die Ernennung von Marcus Bergler zum ... Herr Bergler hat die europäischen kommerziellen Aktivitäten von ... Bevor er sich Qforma anschloss, war er in ... Customer Information, als Vertriebsteam-Leiter Deutschland bei IMS Health ...
(Date:7/22/2014)... Greenville, SC (PRWEB) July 22, 2014 ... chorus of those who have recognized that the greatest ... inefficient, and far too often needlessly deadly while trying ... the multitude of quasi-experts seeking to transform an enormous ... detail.” , Dr. Williams, in his continuing series of ...
(Date:7/21/2014)... amount of tension to a chain of carbon atoms ... insulator, according to Rice University scientists. , Stretching the ... of carbon atoms -- by just 3 percent can ... might find useful for mechanically activated nanoscale electronics and ... Yakobson and his colleagues appears in the American Chemical ...
Breaking Biology Technology:Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 2Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 3Qforma gibt Schaffung des neuen Postens als General Manager in Europa bekannt 2Dr. Ira Williams Asks What’s Wrong With Jonathan Bush’s Book, Where Does It Hurt? 2Carbyne morphs when stretched 2Carbyne morphs when stretched 3
... DIEGO, June 2 Amylin Pharmaceuticals,Inc. (Nasdaq: ... present new data,for its FDA-approved diabetes drugs, BYETTA(R) ... pipeline diabetes and,obesity drug candidates at the American ... in San Francisco, CA from June 6 to,10. ...
... Alternative Reproductive Resources,(ARR), a leading Chicago-based agency ... mothers, has announced a program designed,to remove some ... process., Called Extended Choice, the program offers ... selected egg donors during a 72-hour period.,This means ...
... The Scarborough Hospital (TSH),Canada,s largest urban community hospital, ... communications between physicians. The,implementation of Chyma(TM) for their ... the busy ER departments at the two hospital ... of general medicine., "Chyma(TM) reflects the commitment ...
Cached Biology Technology:Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 2Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 3Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 4Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 5Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 6Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 7ARR Offers Parents 'Extended Choice' in Egg Donor Selections 2Canada's Largest Urban Community Hospital Chooses Chyma(TM) On-Call Physician Scheduling Technology 2
(Date:7/22/2014)... that drinking milk helps make their bones strong or that fish ... idea that if something is good for us, it must surely ... of Consumer Research , when children hear about the benefits of ... that when food is presented to children as making them strong ... how to read or count, they would conclude the food is ...
(Date:7/22/2014)... in schoolyards that feature natural habitats and trees and ... and inattention, according to a University of Colorado Boulder ... such settings also provide stress-reducing benefits for youth, according ... & Place. The study is one of the ... between student access to green settings and stress. , ...
(Date:7/22/2014)... July 22, 2014, Cleveland: A type of immune ... diseases, such as Alzheimer,s disease and multiple sclerosis ... brain injury (TBI) and may slow the progression ... published today in the online journal Nature ... Bruce Trapp, PhD, Chair of the Department of ...
Breaking Biology News(10 mins):Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 2Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 3Cleveland Clinic researchers discover neuroprotective role of immune cell 2
... Endeavour International Corporation (NYSE Amex: END ) (LSE: ENDV) will ... on Monday, May 17, 2010 in London .   , ... William L. Transier , chairman, chief ... and operational plans at 11:05 a.m. British Summer Time and ...
... DENVER , April 26 M.D.C. Holdings, Inc. (NYSE: MDC ... of twenty-five cents ($.25) per share on the Company,s common stock. ... record on Wednesday, May 12, 2010 . , ... M.D.C. Holdings, Inc. , , , ...
... LOS ANGELES , April 26 Northrop Grumman Corporation (NYSE: ... Virginia , concluding a search that also included the state of ... , , ... as the home for our new corporate office.  Virginia, Maryland and ...
Cached Biology News:M.D.C. Holdings Declares Quarterly Cash Dividend 2Northrop Grumman Selects Virginia for New Corporate Office 2Northrop Grumman Selects Virginia for New Corporate Office 3
... and supplies, for 10 chips, provides ... perform high-sensitivity RNA analysis (picogram levels) ... automated electrophoresis system. Supplied are 1,250 ... HighSens stain, 20 microliters RNA ladder, ...
... 3-(3,5-Dibromo-4-hydroxy-benzoyl)-2-ethyl-benzofuran-6-sulfonicacid-(4-(thiazol-2-ylsulfamyl)-phenyl)-amide White solid. PROTECT ... A cell-permeable sulfanamido-benzbromarone compound that acts ... allosteric inhibitor of PTP1B (IC 50 ... μM for PTP1B 403 and ...
...
... White walled plates enhance luminescent signals ... fluorescence,• Not treated (or medium binding) ... and binds biomolecules through passive interactions,• ... of large molecules, such as antibodies, ...
Biology Products: